BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15266530)

  • 1. Botulinum toxin injections for the treatment of spasmodic dysphonia.
    Watts CC; Whurr R; Nye C
    Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Thompson AR
    J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
    Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
    Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
    Langeveld TP; Drost HA; Baatenburg de Jong RJ
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis.
    Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P
    J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
    Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
    J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment for spasmodic dysphonia.
    Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
    Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
    Meleca RJ; Hogikyan ND; Bastian RW
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
    Whurr R; Nye C; Lorch M
    Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.